Table 1.

Characteristics of patients at baseline

	Rituximab		Ofatumumab
	Steroid dependence	Multidrug dependence	Multidrug dependence
Patients (n)	30	100	37
Treatments (n)	68	268	64
Gender (M/F)	22/8	67/33	21/16
Age (years) [mean (range)]	4.5 (3–7.7)	9.2 (7–13)	11.1 (6–14)
Age at onset (years) [mean (range)]	3.2 (1–5)	3.1 (2–5)	2.1 (1.5–4)
MCD (n)	1	13	3
FSGS (n)	0	9	4
IgMN (n)	0	7	1
Prednisone	30 (100)	100 (100)	37 (100)
ACE‐I/ARB (n)	0	24	1
Cyclosporine A (n)	0	69	19
Tacrolimus (n)	0	30	15
MMF (n)	0	13	7

ACE‐I, angiotensin‐converting enzyme inhibitors; ARB, angiotensin receptor blockers; FSGS, focal segmental glomerulosclerosis; IgMN, immunoglobulin M deposits nephropathy; MCD, minimal change disease; MMF, mofetil mycophenolate